A Critical Role for the Carboxy Terminal Region of the Proprotein Convertase, PACE4A, in the Regulation of Its Autocatalytic Activation Coupled with Secretion

By Taniguchi T.   Kuroda R.   Sakurai K.   Nagahama M.   Wada I.   Tsuji A.   Matsuda Y.  

Biochemical and Biophysical Research Communications, Vol. 290, Iss. 2, 2002-01 ,pp. : 878-884

Elsevier

Access to resources Recommend Favorite

Quercetin‐3‐glucoside increases low‐density lipoprotein receptor (LDLR) expression, attenuates proprotein convertase subtilisin/kexin 9 (PCSK9) secretion, and stimulates LDL uptake by Huh7 human hepatocytes in culture

By  

FEBS Open Bio, Vol. 4, Iss. 1, 2014-01 ,pp. : 755-762

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence

By Cicero Arrigo FG   Tartagni Elisa   Ertek Sibel  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 6, 2014-06 ,pp. : 863-868

Informa Healthcare

Access to resources Recommend Favorite

Cleavage specificity of the subtilisin-like protease C1 from soybean

By Boyd P.M.   Barnaby N.   Tan-Wilson A.   Wilson K.A.  

BBA - Protein Structure and Molecular Enzymology, Vol. 1596, Iss. 2, 2002-04 ,pp. : 269-282

Elsevier

Access to resources Recommend Favorite

Expression of hsp16 in response to nucleotide depletion is regulated via the spc1 MAPK pathway in Schizosaccharomyces pombe

By Taricani L.   Feilotter H.E.   Weaver C.   Young P.G.  

Nucleic Acids Research, Vol. 29, Iss. 14, 2001-07 ,pp. : 3030-3040

Oxford University Press

Access to resources Recommend Favorite